Diagnostic Test Accuracy Protocol

You have free access to this content

Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies

  1. Daniel HJ Davis1,*,
  2. Sam T Creavin2,
  3. Anna Noel-Storr3,
  4. Terry J Quinn4,
  5. Nadja Smailagic5,
  6. Chris Hyde6,
  7. Carol Brayne1,
  8. Rupert McShane3,
  9. Sarah Cullum7

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 28 MAR 2013

Assessed as up-to-date: 21 DEC 2012

DOI: 10.1002/14651858.CD010460


How to Cite

Davis DHJ, Creavin ST, Noel-Storr A, Quinn TJ, Smailagic N, Hyde C, Brayne C, McShane R, Cullum S. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD010460. DOI: 10.1002/14651858.CD010460.

Author Information

  1. 1

    University of Cambridge, Department of Public Health and Primary Care, Cambridge, UK

  2. 2

    University of Bristol, School of Social and Community Medicine, Bristol, UK

  3. 3

    University of Oxford, Radcliffe Department of Medicine, Oxford, UK

  4. 4

    University of Glasgow, Cardiovascular and Medical Sciences, Glasgow, UK

  5. 5

    University of Cambridge, Institute of Public Health, Cambridge, UK

  6. 6

    University of Exeter Medical School, University of Exeter, Peninsula Technology Assessment Group (PenTAG), Exeter, UK

  7. 7

    Bristol University, Academic Unit of Psychiatry, School of Social and Community Medicine, Bristol, UK

*Daniel HJ Davis, Department of Public Health and Primary Care, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0SR, UK. dhjd2@cam.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 28 MAR 2013

SEARCH

References

Additional references

Alzheimer's Society 2007
  • Alzheimer’s Society. Dementia UK: A report into the prevalence and cost of dementia prepared by the Personal Social Services Research Unit (PSSRU) at the London School of Economics and the Institute of Psychiatry at King’s College London, for the Alzheimer’s Society. Alzheimer's Society, 2007.
APA 1994
  • Diagnostic and statistical manual of mental disorders (DSM-IV). Amercian Psychiatric Association. Washington DC: American Psychiatric Association, 1994.
Birks 2006
  • Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006;3:Art. No.: CD005593.
Borson 2000
Bourne 2007
  • Bourne J. Improving services and support for people with dementia. National Audit Office,. UK, 2007.
Boustani 2003
  • Boustani M, Peterson B, Hanson L, Harris R, Lohr KN. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2003;138:927-37.
Brown 2009
  • Brown J, Pengas G, Dawson K, Brown LA, Clatworthy P. Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study. BMJ 2009;338:b2030.
Bruscoli 2004
CFAS 2001
  • Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169-75.
Clare 2003
  • Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database of Systematic Reviews 2003;4:CD003260.
Crawford 2012
de Silva 2010
DTA Handbook Chapter 10
  • Macaskill P, Gatsonis C, Deeks JJ, Harbord R, Yemisi Takwoingi Y. Chapter 10: Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Chapter%2010%20-%20Version%201.0.pdf. The Cochrane Collaboration, 2010.
DTA Handbook Chapter 4
  • Smidt N, Deeks J, Moore T. Chapter 4: Guide to the contents of a Cochrane review and protocol. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Handbook1CC_Chapter04_101.pdf. The Cochrane Collaboration, 2010.
DTA Handbook Chapter 6
  • Bossuyt PM, Leeflang MM. Chapter 6: Developing criteria for including studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Chapter06-Including-Studies%20%28September-2008%29.pdf. The Cochrane Collaboration, 2008.
DTA Handbook Chapter 7
  • de Vet HCW, Eisinga A, Riphagen II, Aertgeerts B, Pewsner D. Chapter 7: Searching for Studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Chapter07-Searching-%28September-2008%29.pdf. The Cochrane Collaboration, 2008.
DTA Handbook Chapter 9
  • Reitsma JB, Rutjes AWS, Whiting P, Vlassov VV, Leeflang MMG, Deeks JJ. Chapter 9: Assessing methodological quality. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/ch09_Oct09.pdf. The Cochrane Collaboration, 2009.
Ferri 2005
Folstein 1975
Glanville 2012
  • Glanville JM, Cikalo M, Crawford F, Dozier M, McIntosh H. Handsearching did not yield additional unique FDG-PET diagnostic test accuracy studies compared with electronic searches: a preliminary investigation. Research Synthesis Methods September 2012;3(3):202-13.
Ismail 2010
Jack 2011
  • Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7:257-62.
Leeflang 2008
  • Leeflang MM, Moons KG, Reitsma JB, Zwinderman AH. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clinical Chemistry 2008;54:729-37.
Luengo-Fernandez 2012
Lund 1994
Matthews 2008
Matthews 2009
  • Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Medicine 2009;6:e1000180.
McKeith 1996
  • McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International workshop. Neurology 1996;47:1113-24.
McKeith 2005
McKhann 1984
  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
McKhann 2011
  • McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7:263-9.
McShane 2006
  • McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database of Systematic Reviews 2006;3:CD003154.
Mioshi 2006
Mirra 1991
  • Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
Mitchell 2009
Nasreddine 2005
Newell 1999
  • Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. Journal of Neuropathology and Experimental Neurology 1999;58:1147-55.
NICE 2006
  • Dementia: supporting people with dementia and their careers in health and social care. National Institute for Health and Clinical Excellence 2006; Vol. Clinical Guideline 42.
Petersen 1999
Petersen 2004
Reitsma 2005
  • Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58:982-90.
Roman 1993
  • Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
Savva 2009
Scheltens 2011
Whiting 2011
  • Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155:529-36.
Whiting 2011a
  • Whiting P, Westwood M, Beynon R, Burke M, Sterne J A, Glanville J. Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies. Journal of Clinical Epidemiology 2011;64:602-7.
WHO 1992
  • World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva, Switzerland: WHO,. Geneva: World Health Organization, 1992.
Wimo 2010
  • Wimo A, Prince M. World Alzheimer's Report 2010: the global economic impact of dementia. London, UK: Alzheimer’s Disease International (ADI),. London, UK, 2010.
Winblad 2004